- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Sectors
Carisma charms its way to $59m
Penn Medicine contributed to a $12m extension for the cancer immunotherapy developer's series B round, which already inlcuded Livzon, Merck & Co and AbbVie.
Mar 2, 2021Tenaya takes in $106m
RTW Investments has a series C for the UT Southwestern and Gladstone Institutes spinout, which will progress its lead asset into the clinic.
Mar 2, 2021MDLive heads to Evernorth
Sutter Health, Novo, Sentara and Health Care Service Corporation are set to exit the virtual healthcare provider in an acquisition of undisclosed size.
Mar 2, 2021CorPower uncorks new funding
Midroc Europe led a round that increzased the wave energy technology developer's total equity funding to $25m.
Mar 2, 2021Rokk3r acquires AdMobilize
Axel Springer has exited the advertising data technology provider, which has been bought by Rokk3r together with its Matrix Labs spinoff for $19.5m.
Mar 2, 2021Armorblox stocks up with $30m
Siemens' Next47 unit led a series B round for the email security platform developer, increasing its total funding to more than $46m.
Mar 1, 2021PharmEasy sells stake to CDPQ
The pension fund will pay an undisclosed sum for a 2% stake in API Holdings, the owner of online drugstore PharmEasy backed by Ascent Health and Medi Assist.
Mar 1, 2021Manbang Group loads up billion-dollar IPO
Tencent, SoftBank and Alphabet are in line for exits after the trucking services provider confidentially filed to float in a US initial public offering sized above $1bn.
Mar 1, 2021EG 427 receives $14m
Satt Paris-Saclay portfolio company EG 427 has collected $14m in its first funding round.
Mar 1, 2021Legend Capital unveils 10-figure renminbi fund
Xiangcheng Financial Holdings is among the backers for the first close of the Legend Holdings spinoff's sixth renminbi-denominated vehicle.
Mar 1, 2021AstraZeneca achieves Moderna stake sale
AstraZeneca likely received over $1bn from selling its shares, having invested $140m in the publicly listed covid-19 vaccine developer in 2015.
Mar 1, 2021Skydio soars with $170m
Siemens’ Next47 subsidiary has returned to back the unmanned aerial vehicle technology producer’s latest round, valuing it above $1bn.
Mar 1, 2021Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation


